中国药业2017，Vol.26Issue(15)：57-58,2.DOI:10.3969/j.issn.1006-4931.2017.15.019
依达拉奉联合阿替普酶治疗急性脑梗死23例疗效观察
Clinical Observation of Edaravone Combined with Batroxobin for Treating Acute Cerebral Infarction in 23 Cases
胡庆华1
作者信息
- 1. 河北省香河县心脑血管病医院,河北廊坊 065400
- 折叠
摘要
Abstract
Objective To investigate the clinical efficacy of edaravone combined with batroxobin in the treatment of acute cerebral in-farction. Methods Totally 49 patients with acute cerebral infarction in our hospital from February 2015 to April 2016 were randomly divided into the experimental group ( 23 cases ) and the control group ( 26 cases ) . The control group was treated with batroxobin, on this basis, the experimental group was treated with edaravone. Results After treatment, the NIHSS score, IL-6 and hs-CRP in the experi-mental group were better than those in the control group ( P < 0. 05 ) . Conclusion Edaravone combined with batroxobin in the treatment of acute cerebral infarction has good effect, it is worthy of clinical promtion.关键词
依达拉奉/阿替普酶/急性脑梗死/联合治疗Key words
edaravone/batroxobin/acute cerebral infarction/combined treatment分类
医药卫生引用本文复制引用
胡庆华..依达拉奉联合阿替普酶治疗急性脑梗死23例疗效观察[J].中国药业,2017,26(15):57-58,2.
